Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence.

ABSTRACT:

Introduction

Despite being frequently diagnosed, there has been very limited study of efficacious treatments for schizoaffective disorder. Paliperidone had been approved for the treatment of schizoaffective disorder, and a recently completed relapse prevention study of the use of a once-monthly injectable paliperidone formulation has also led to an indication for that preparation to treat schizoaffective disorder.

Methods

To review the efficacy and tolerability of paliperidone for schizoaffective disorder, we conducted a systematic literature search of studies of paliperidone in the treatment of schizoaffective disorder, and briefly reviewed evidence regarding the somewhat controversial nature of that diagnostic entity.

Results

We located several studies of the use of

SUBMITTER: Greenberg WM 

PROVIDER: S-EPMC4685865 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature